Retail-Drug Stores and Proprietary Stores

Corporate GovernanceSep 28, 2026, 06:46 AM

111, Inc. Forms Special Committee to Evaluate Strategic Alternatives

AI Summary

111, Inc. announced the establishment of a Special Committee by its Board of Directors. The committee, composed of three independent directors, will evaluate a previously announced preliminary, non-binding proposal and explore other potential strategic alternatives. The Board cautioned shareholders that no decisions have been made and there is no certainty that any transaction will be approved or consummated.

Key Highlights

111, Inc. Board of Directors establishes a Special Committee.
Special Committee comprises three independent directors: Jian Sun (Chairman), Nee Chuan Teo, and Jun Luo.
Committee will evaluate a preliminary, non-binding proposal letter dated September 16, 2026.
Committee will also consider other potential strategic alternatives for the Company.
Board cautions shareholders that no decisions have been made regarding the proposal or alternatives.

View SEC Filing

Retail-Drug Stores and Proprietary Stores

111, Inc.

Price Impact